Lipoic acid, but not tempol, preserves vascular compliance and decreases medial calcification in a model of elastocalcinosis

Brazilian Journal of Medical and Biological Research

Volumn 47, Issue 2, 2014, Pages 119-127

  Bassi, E ^a   Liberman, M ^a,b   Martinatti, M K ^a   Bortolotto, L A ^a   Laurindo, F R M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

Author keywords

Antioxidants; Atherosclerosis; Lipoic acid; Oxidative stress; Vascular calcification

Indexed keywords

ACETYLCHOLINE; CALCIUM; CREATININE; GLUCOSE; HYDROGEN PEROXIDE; NITRIC OXIDE; NORADRENALIN; PHOSPHORUS; SUPEROXIDE; TEMPOL; THIOCTIC ACID; UREA; AMINE OXIDE; SPIN LABELING;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL STIFFNESS; ARTERY CALCIFICATION; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BLOOD VESSEL COMPLIANCE; BLOOD VESSEL REACTIVITY; CALCINOSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; ECHOGRAPHY; ELASTIC FIBER; ELASTOCALCINOSIS; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING; KIDNEY DISEASE; MACROPHAGE; MALE; MEDIAN EFFECTIVE CONCENTRATION; NONHUMAN; RABBIT; THORACIC AORTA; ANIMAL; ARTERIOSCLEROSIS; CHEMICALLY INDUCED; COMPLIANCE (PHYSICAL); DISEASE MODEL; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; SPIN LABELING; VASCULAR CALCIFICATION; VASCULAR RESISTANCE; VASOCONSTRICTION;

ANIMALS; AORTA, THORACIC; ARTERIOSCLEROSIS; COMPLIANCE; CYCLIC N-OXIDES; DISEASE MODELS, ANIMAL; MALE; RABBITS; SPIN LABELS; THIOCTIC ACID; VASCULAR CALCIFICATION; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 84896469543     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/1414-431X20133193     Document Type: Article

References (30)

1. Rennenberg RJ, Kessels AG, Schurgers LJ, van Engelshoven JM, de Leeuw PW, Kroon AA. Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis. Vasc Health Risk Manag 2009; 5: 185-197, doi: 10.2147/VHRM.S4822.
2. Stinghen AE, Bucharles S, Riella MC, Pecoits-Filho R. Immune mechanisms involved in cardiovascular complications of chronic kidney disease. Blood Purif 2010; 29: 114-120, doi: 10.1159/000245636.
3. Shao JS, Aly ZA, Lai CF, Cheng SL, Cai J, Huang E, et al. Vascular Bmp Msx2 Wnt signaling and oxidative stress in arterial calcification. Ann N Y Acad Sci 2007; 1117: 40-50, doi: 10.1196/annals.1402.075.
4. Santos CX, Tanaka LY, Wosniak J, Laurindo FR. Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase. Antioxid Redox Signal 2009; 11: 2409-2427, doi: 10.1089/ars.2009.2625.
5. Liberman M, Bassi E, Martinatti MK, Lario FC, Wosniak J Jr, Pomerantzeff PM, et al. Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification. Arterioscler Thromb Vasc Biol 2008; 28: 463-470, doi: 10.1161/ATVBAHA.107.156745.
6. Fernandes DC, Medinas DB, Alves MJ, Augusto O. Tempol diverts peroxynitrite/carbon dioxide reactivity toward albumin and cells from protein-tyrosine nitration to proteincysteine nitrosation. Free Radic Biol Med 2005; 38: 189-200, doi: 10.1016/j.freeradbiomed.2004.09.027.
7. Ogborne RM, Rushworth SA, O'Connell MA. Alpha-lipoic acid-induced heme oxygenase-1 expression is mediated by nuclear factor erythroid 2-related factor 2 and p38 mitogenactivated protein kinase in human monocytic cells. Arterioscler Thromb Vasc Biol 2005; 25: 2100-2105, doi: 10.1161/01.ATV.0000183745.37161.6e.
8. Chen Y, Pearlman A, Luo Z, Wilcox CS. Hydrogen peroxide mediates a transient vasorelaxation with tempol during oxidative stress. Am J Physiol Heart Circ Physiol 2007; 293: H2085-H2092, doi: 10.1152/ajpheart.00968.2006.
9. Chen X, Patel K, Connors SG, Mendonca M, Welch WJ, Wilcox CS. Acute antihypertensive action of Tempol in the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 2007; 293: H3246-H3253, doi: 10.1152/ajpheart.00957.2007.
10. Midaoui AE, Elimadi A, Wu L, Haddad PS, de Champlain J. Lipoic acid prevents hypertension, hyperglycemia, and the increase in heart mitochondrial superoxide production. Am J Hypertens 2003; 16: 173-179, doi: 10.1016/S0895-7061(02)03253-3.
11. Zhang WJ, Bird KE, McMillen TS, LeBoeuf RC, Hagen TM, Frei B. Dietary alpha-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein Edeficient and apolipoprotein E/low-density lipoprotein receptor-deficient mice. Circulation 2008; 117: 421-428, doi: 10.1161/CIRCULATIONAHA.107.725275.
12. Lalaoui MZ, El Midaoui A, de Champlain J, Moreau P. Is there a role for reactive oxygen species in arterial medial elastocalcinosis? Vascul Pharmacol 2007; 46: 201-206, doi: 10.1016/j.vph.2006.10.006.
13. Kim H, Kim HJ, Lee K, Kim JM, Kim HS, Kim JR, et al. Alphalipoic acid attenuates vascular calcification via reversal of mitochondrial function and restoration of Gas6/Axl/Akt survival pathway. J Cell Mol Med 2012; 16: 273-286, doi: 10.1111/j.1582-4934.2011.01294.x.
14. Coppey LJ, Gellett JS, Davidson EP, Yorek MA. Preventing superoxide formation in epineurial arterioles of the sciatic nerve from diabetic rats restores endothelium-dependent vasodilation. Free Radic Res 2003; 37: 33-40, doi: 10.1080/1071576021000028442.
15. Sola S, Mir MQ, Cheema FA, Khan-Merchant N, Menon RG, Parthasarathy S, et al. Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study. Circulation 2005; 111: 343-348, doi: 10.1161/01.CIR.0000153272.48711.B9.
16. Drolet MC, Arsenault M, Couet J. Experimental aortic valve stenosis in rabbits. J Am Coll Cardiol 2003; 41: 1211-1217, doi: 10.1016/S0735-1097(03)00090-1.
17. Bortolotto LA, Hanon O, Franconi G, Boutouyrie P, Legrain S, Girerd X. The aging process modifies the distensibility of elastic but not muscular arteries. Hypertension 1999; 34: 889-892, doi: 10.1161/01.HYP.34.4.889.
18. Kingwell BA, Arnold PJ, Jennings GL, Dart AM. Spontaneous running increases aortic compliance in Wistar-Kyoto rats. Cardiovasc Res 1997; 35: 132-137, doi: 10.1016/S0008-6363(97)00079-5.
19. Laurindo FR, Pedro MA, Barbeiro HV, Pileggi F, Carvalho MH, Augusto O, et al. Vascular free radical release. Ex vivo and in vivo evidence for a flow-dependent endothelial mechanism. Circ Res 1994; 74: 700-709, doi: 10.1161/01.RES.74.4.700.
20. Abedin M, Tintut Y, Demer LL. Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 2004; 24: 1161-1170, doi: 10.1161/01.ATV.0000133194.94939.42.
21. Kahonen M, Nappi S, Jolma P, Hutri-Kahonen N, Tolvanen JP, Saha H, et al. Vascular influences of calcium supplementation and vitamin D-induced hypercalcemia in NaCl-hypertensive rats. J Cardiovasc Pharmacol 2003; 42: 319-328, doi: 10.1097/00005344-200309000-00002.
22. Augusto O, Trindade DF, Linares E, Vaz SM. Cyclic nitroxides inhibit the toxicity of nitric oxide-derived oxidants: mechanisms and implications. An Acad Bras Cienc 2008; 80: 179-189, doi: 10.1590/S0001-37652008000100013.
23. Serrander L, Cartier L, Bedard K, Banfi B, Lardy B, Plastre O, et al. NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem J 2007; 406: 105-114, doi: 10.1042/BJ20061903.
24. Trujillo M, Folkes L, Bartesaghi S, Kalyanaraman B, Wardman P, Radi R. Peroxynitrite-derived carbonate and nitrogen dioxide radicals readily react with lipoic and dihydrolipoic acid. Free Radic Biol Med 2005; 39: 279-288, doi: 10.1016/j.freeradbiomed.2005.03.014.
25. Li PF, Dietz R, von Harsdorf R. Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells. Circulation 1997; 96: 3602-3609, doi: 10.1161/01.CIR.96.10.3602.
26. Byon CH, Javed A, Dai Q, Kappes JC, Clemens TL, Darley Usmar VM, et al. Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem 2008; 283: 15319-15327, doi: 10.1074/jbc.M800021200.
27. Clempus RE, Sorescu D, Dikalova AE, Pounkova L, Jo P, Sorescu GP, et al. Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 2007; 27: 42-48, doi: 10.1161/01.ATV.0000251500.94478.18.
28. Dao HH, Essalihi R, Bouvet C, Moreau P. Evolution and modulation of age-related medial elastocalcinosis: impact on large artery stiffness and isolated systolic hypertension. Cardiovasc Res 2005; 66: 307-317, doi: 10.1016/j.cardiores.2005.01.012.
29. Yamada S, Taniguchi M, Tokumoto M, Toyonaga J, Fujisaki K, Suehiro T, et al. The antioxidant tempol ameliorates arterial medial calcification in uremic rats: important role of oxidative stress in the pathogenesis of vascular calcification in chronic kidney disease. J Bone Miner Res 2012; 27: 474-485, doi: 10.1002/jbmr.539.
30. Steinhubl SR. Why have antioxidants failed in clinical trials? Am J Cardiol 2008; 101: 14D-19D, doi: 10.1016/j.amjcard.2008.02.003.